-
2000 January 18
Company Description
CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects.
CanBas is a biopharmaceutical company that research and develops anti-cancer drugs. The company develops CBP501 which completes phase II clinical trials for the treatment of malignant pleural mesothelioma and non-small cell lung cancers. It also develops CBS9106, a reversible XPO-1 inhibitor for the treatment of solid tumors. CanBas is a Japan-based company that was founded in 2000.
-
Manufacturer:
Science and Engineering -
Formed:
January 18, 2000 -
Company Website:
-
Company E-mail:
-
Company Address:
NumazuJapan2-2-1,, Otemachi -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits